Katy H. P. Moore - Concepedia

Author

Katy H. P. Moore

Also Known As

Beena Mistry, K. H. P. Moore, K.H.P. Moore, K. H. P. Moore, Katy H. P. Moore, Katy H.P. Moore, Katy HP Moore, Katy Moore, The University of North Carolina at Chapel Hill University Libraries, Vusumuzi Shabangu

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Research Triangle Park Foundation Wellcome Library GlaxoSmithKline (United States)University of North Carolina at Chapel Hill GlaxoSmithKline (United Kingdom)

About

Katy H. P. Moore is an author at Research Triangle Park Foundation specializing in medicine, pharmacology, and biostatistics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	207
2	Pharmacology	2	2	207
3	Engineering	1	1	33
4	Biostatistics	1	1	33
5	Antimicrobial Pharmacokinetics	1	1	18

Katy H. P. Moore

Publications

783

Citations

H-Index

Page 1

	Year	Citations
Pharmacokinetics and Antiretroviral Activity of Lamivudine Alone or When Coadministered with Zidovudine in Human Immunodeficiency Virus Type 1–Infected Pregnant Women and Their Offspring Jagidesa Moodley, Dhayendre Moodley, Kubendran Pillay, The Journal of Infectious Diseases Drug InteractionsHiv-1 RnaAntiretroviral ActivityTreatment And PreventionNeurovirology	1998	189
Pharmacokinetics of lamivudine administered alone and with trimethoprim-sulfamethoxazole* Katy H. P. Moore, Geoffrey J. Yuen, Ralph H. Raasch, Clinical Pharmacology & Therapeutics	1996	133
The pharmacokinetics of lamivudine phosphorylation in peripheral blood mononuclear cells from patients infected with HIV-1 Katy H. P. Moore, J E Barrett, Shuching Shaw, AIDS	1999	128
Pharmacokinetics of Zidovudine and Lamivudine in Neonates following Coadministration of Oral Doses Every 12 Hours Kubendran Pillay, Mark Johnson, Katy H. P. Moore, The Journal of Clinical Pharmacology	2001	58
Lamivudine/Zidovudine as a Combined Formulation Tablet: Bioequivalence Compared with Lamivudine and Zidovudine Administered Concurrently and the Effect of Food on Absorption Katy H. P. Moore, Shuching Shaw, Aziz Laurent, The Journal of Clinical Pharmacology	1999	52
Population Pharmacokinetics of Lamivudine in Adult Human Immunodeficiency Virus-Infected Patients Enrolled in Two Phase III Clinical Trials Katy H. P. Moore, Geoffrey J. Yuen, Elizabeth K. Hussey, Antimicrobial Agents and Chemotherapy	1999	41
Statistical Issues in a Modeling Approach to Assessing Bioequivalence or PK Similarity with Presence of Sparsely Sampled Subjects Chuanpu Hu, Katy H. P. Moore, Yong H. Kim, Journal of Pharmacokinetics and Pharmacodynamics EngineeringStatistical IssuesPk SimilarityComputational BiologySparsely Sampled Subjects	2004	33
The Bioavailability of the Novel Nonnucleoside Reverse Transcriptase Inhibitor GW420867X Is Unaffected by Food in Healthy Male Volunteers Lindsey Cass, Katy H. P. Moore, Nigel Dallow, The Journal of Clinical Pharmacology	2001	27
Oral zidovudine during labor to prevent perinatal HIV transmission, Bangkok: tolerance and zidovudine concentration in cord blood C Bhadrakom, R. J. Simonds, Joanne V. Mei, AIDS	2000	27
Rational Dose Selection for a Nonnucleoside Reverse Transcriptase Inhibitor through Use of Population Pharmacokinetic Modeling and Monte Carlo Simulation George L. Drusano, Katy H. P. Moore, J P Kleim, Antimicrobial Agents and Chemotherapy	2002	23

Page 1